Andrea has more than 20 years experience in advising her clients in relation to all matters of intellectual property law. Her main focus lies on the commercialisation of IP rights.
She is one of Germany's top licensing experts and has significant experience in technology transfer (in particular in and out-licensing deals) and research and development projects. Among her further key areas of expertise are brand licensing and franchising systems, the protection of trade secrets, branding and advertising campaigns, the launch of new products, joint ventures and IP-related transactions.
Andrea is an active member of the Life Science & Healthcare sector as well as the Retail & Consumer sector and has longstanding experience in supporting clients from these industries in all contractual aspects involving the protection, the development and the commercialisation of IP Rights as well as regulatory issues.
Since many years JUVE recognizes her as a top IP expert with extensive experience in complex matters. According to Intellectual Asset Management 2022 Andrea is one of Germany’s leading experts in IP related transactions (licenses).
She regularly speaks at conferences and has authored and co-authored several books on IP licensing and technology transfer.
Andrea studied law in Göttingen, Hong Kong and Bonn. She obtained a doctorate from the University of Jena in 2001.
Prior to joining Osborne Clarke in 2014, she was a partner at Baker & McKenzie since 2009.
PL BioScience
Osborne Clarke has advised PL BioScience GmbH in a EUR 7.8 million Series A financing. Read more.
DemoUp Cliplister
Osborne Clarke has advised the sellers of the Software-as-a-Service (SaaS) platform DemoUp Cliplister on its sale to the E-Commerce Software Group of Bregal Unternehmerkapital. Read more.
Octane Group
Osborne Clarke has advised the Canadian Octane Group on the acquisition of Aesculap AG's stake in Reutlingen-based TETEC Tissue Engineering Technologies AG on an interdisciplinary basis, read more.
Brightlands Venture Partners and TechVision Fonds
Osborne Clarke has advised Brightlands Venture Partners and TechVision Fonds on their investment in the Organ Vitality Tech start-up Vivalyx GmbH as part of a seed financing round. Read more.
Nosh.bio
Osborne Clarke advises Nosh.bio on seed funding round, read more
Cylib
Osborne Clarke advises battery recycling start-up Cylib on seed funding, read more
Bluu Biosciences
Osborne Clarke advises Bluu Biosciences in EUR 7 Mio financing round, read more
Usercentrics
Osborne Clarke advises Usercentrics on multi-million Euro financing round, read more
Deutsche Bahn
Advising on the acquisition of a majority stake in the electric vehicle ride-share specialists CleverShuttle.
Insights
“Commercially Reasonable Efforts" in Licensing Agreements: What needs to be considered?
Virtual tops, real trademarks: how in the US and Europe to navigate fashion IP in the metaverse
IP basics: what to think about when entering the UK and EU markets (trade marks, copyright, designs)
Compassionate Use in Europe
How will IoT transform industry in Asia?
TOP SECRET! How have Member States implemented the new EU Trade Secrets Directive?
All businesses hold confidential information. For some, confidential know-how can be at least as important as registered IP such as...
What will Brexit mean for the Life Sciences sector – in a deal or a no deal scenario?
With less than four months until the UK officially leaves the EU, amid confidence votes and delayed votes in the...